Back to Journals » Journal of Blood Medicine » Volume 10

Thrombotic events with recombinant activated factor VII (rFVIIa) in approved indications are rare and associated with older age, cardiovascular disease, and concomitant use of activated prothrombin complex concentrates (aPCC)

Total article views   HTML views PDF downloads Totals
14,713 Dovepress* 13,247+ 2,133 15,380
PubMed Central* 1,466 337 1,803
Totals 14,713 2,470 17,183
*Since 18 September 2019
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar